Expression and localization of thymidine phosphorylase/platelet‐derived endothelial cell growth factor in skin and cutaneous tumors
- 1 July 1999
- journal article
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 26 (6) , 287-294
- https://doi.org/10.1111/j.1600-0560.1999.tb01846.x
Abstract
Thymidine phosphorylase/platelet‐derived endothelial cell growth factor (TPase/PD‐ECGF) is a catabolic enzyme that has been shown to be chemotactic for endothelial cells in vitro and angiogenic in vivo. TPase/PD‐ECGF expression is increased in a variety of tumors. In the skin, TPase is active in normal keratinocytes in vitro and in vivo. Our objective was to study the expression and localization of TPase/PD‐ECGF by immunohistochemical analysis in normal skin and cutaneous tumors and to correlate this information with enzymatic activity of TPase. TPase/PD‐ECGF expression was observed in keratinocytes with intense staining of the infundibulum of hair follicles but no staining of hair bulbs. Expression localized primarily to the nucleus of keratinocytes in the basal layer but was more intense and cytoplasmic in suprabasal keratinocytes. Increased expression of TPase/PD‐ECGF in differentiated cells was confirmed by in vitro studies of TPase activity. In cutaneous tumors, there was positive staining for TPase/PD‐ECGF in squamous cell carcinomas (10/10), eccrine poromas (3/4), eccrine syringomas (4/4), trichoepitheliomas (1/3), and tumors of the follicular infundibulum (2/3) and melanomas (5/8). There was no staining of any intradermal nevi (0/2), basal cell carcinomas (0/10) or Merkel cell carcinoma (0/1). We conclude TPase/PD‐ECGF is found throughout the epidermis and its expression increases with differentiation of keratinocytes. In cutaneous tumors, expression of TPase/PD‐ECGF may be linked to the cell of origin of the tumor as well as the tumor's degree of differentiation.Keywords
This publication has 35 references indexed in Scilit:
- Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermisBritish Journal of Dermatology, 1997
- Platelet-derived endothelial cell growth factor (Thymidine Phosphorylase) expression in lung cancerThe Journal of Pathology, 1997
- Clinical significance of the determination of angiogenic factorsEuropean Journal Of Cancer, 1996
- The activity and expression of thymidine phosphorylase in human solid tumoursEuropean Journal Of Cancer, 1996
- Identification and Characterization of a Cell Surface Proteoglycan on KeratinocytesJournal of Investigative Dermatology, 1992
- Platelet-derived endothelial cell growth factor has thymidine phosphorylase activityBiochemical and Biophysical Research Communications, 1992
- Elevated Thymidine Phosphorylase Activity in Psoriatic Lesions Accounts for the Apparent Presence of an Epidermal “Growth Inhibitor,” But Is Not in Itself Growth InhibitoryJournal of Investigative Dermatology, 1991
- Local and Systemic Implications of Thymidine Catabolism by Human KeratinocytesaAnnals of the New York Academy of Sciences, 1988
- The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human bloodMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979